Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in MDD and Metabolic Syndrome
NCT00671515Phase 2Completed
- Sponsor
- Joseph Calabrese
- Start
- Apr 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in major depressive disorder (MDD), sponsored by Joseph Calabrese. Started Apr 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00671515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671515.